产品信息
名称 | OCI-Ly3 (人弥漫大 B 细胞淋巴瘤细胞) (STR鉴定正确) |
别称 | OCI-LY3; OCI-ly3; OCI-LY-3; Oci-Ly-3; OCI-Ly 3; OCILY-3; OCI-Ly03; OCI Ly3; OCILY3; Ly3; LY3 |
种属 | 人 |
生长特性 | 悬浮细胞 |
细胞形态 | 圆形细胞,聚团生长 |
冻存条件 | 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮 |
培养方案A(默认) |
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
|
推荐传代比例 | 1:2-1:4 |
推荐换液频率 | 2-3天/次 |
参考资料(来源文献)
背景描述 | established in 1983 from the bone marrow sample of a 52-year-old man with B-cell non-Hodgkin lymphoma (B-NHL, diffuse large B-cell lymphoma, DLBCL, stage 4B) at relapse; cells were described in the literature to be EBV-negative and lacking a classical t(8;14) translocation. Exome and RNA sequence data are available (see Ref 18187 and Exome sequence and RNA-Seq) |
年龄(性别) | 男性;52岁 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 淋巴瘤细胞 |
生物安全等级 | BSL-1 |
倍增时间 | ~24 hours (DSMZ) |
保藏机构 | DSMZ; ACC-761 |
FAQs
Q:{{item.question}}
A:
暂无数据